Answers are grounded in this paper and cite their sources.
Stroke remains a major global health concern, with persistently high rates of morbidity and disability. While advances in acute reperfusion therapy have improved outcomes, post-stroke complications such as glial scar formation continue to limit recovery. The glial scar, though protective in containing injury, also impedes axonal regrowth and neuroplasticity. Emerging preclinical evidence suggests that metabolic dysfunction exacerbates glial scarring, linking systemic metabolic disturbances to impaired neural repair. This editorial re-examines the glial scar through a metabolic lens and proposes the concept of metabolic surveillance—the continuous, multimodal monitoring of systemic and cerebral metabolic status to identify individuals at risk of maladaptive gliosis. Rather than advocating population-level screening, we argue for targeted translational research integrating molecular biomarkers, imaging techniques, and therapeutic modulation. Such a framework could guide personalized interventions to improve recovery after stroke and minimize long-term neuroinflammatory sequelae.
No takes yet. Share an insight, caveat, or question.
Chavda et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: